Dare Bioscience
DARE
DARE
22 hedge funds and large institutions have $2.08M invested in Dare Bioscience in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$74.6K | |
| 2 | +$44.5K | |
| 3 | +$37.5K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$34K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.5K |
Top Sellers
| 1 | -$34.6K | |
| 2 | -$23.9K | |
| 3 | -$11.7K | |
| 4 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
-$10.4K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$10.3K |